Alzheimer's disease: a disorder of cortical cholinergic innervation.
about
A Novel Prolyl Endopeptidase Inhibitor, JTP-4819 - Its Behavioral and Neurochemical Properties for the Treatment of Alzheimer's DiseaseMemory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acidNeural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot studyGalantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learningAllosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptidecDNA cloning and complete sequence of porcine choline acetyltransferase: in vitro translation of the corresponding RNA yields an active proteinDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTCholinergic imaging in dementia spectrum disordersThe Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's DiseaseGetting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric OxideProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentPaying attention to smell: cholinergic signaling in the olfactory bulbLearning and memoryTurning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisHuprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallographyPar-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membraneMecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disordersScopolamine enhances generalization between odor representations in rat olfactory cortexEffect of the 'antidementia drug' pantoyl-GABA on high affinity transport of choline and on the contents of choline and acetylcholine in rat brainReduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in miceBMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer's disease modelsGypsogenin derivatives: an unexpected class of inhibitors of cholinesterases.Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuseGalantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptorsGalantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits.Relations among acute and chronic nicotine administration, short-term memory, and tactics of data analysis.Molecular recognition of rosmarinic acid from Salvia sclareoides extracts by acetylcholinesterase: a new binding site detected by NMR spectroscopy.Structural and dynamical studies of Humanin in water and TFE/water mixture: a molecular dynamics simulation.Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker.Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice.Physostigmine for Alzheimer's disease.beta-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein deltaNeuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned micePertussis toxin-insensitive G protein mediates substance P-induced inhibition of potassium channels in brain neurons.Neurotrophic factors and neurologic disease.Physiological properties of cholinergic and non-cholinergic magnocellular neurons in acute slices from adult mouse nucleus basalis.Reduced Prefrontal Short-Latency Afferent Inhibition in Older Adults and Its Relation to Executive Function: A TMS-EEG Study.
P2860
Q21651042-6FACEAA2-C3C1-44EF-A040-7E6BF0B1DF68Q24530352-5B42E359-1D0F-4BC0-9873-1C244D852957Q24596119-67B3F105-6EE0-4D7F-8D76-67849A6789CEQ24609985-72374E82-4CFF-4D7C-BA8F-9EFFF0322095Q24629740-5E9F601C-1F87-4B6D-92C3-8827AE23E9A8Q24634218-F311FED7-1CC9-45A8-BE5E-2831AE10ACC5Q26749755-1C27A19F-03EC-4946-8B0F-F08155E6FDDDQ26764933-F6794FB7-2C8B-43AA-AE87-169351F88115Q26768487-2B906944-CB09-4E2B-9490-A0CAEC0F684CQ26772294-6BF173A3-86A2-4E10-BDB1-32464FE5020DQ26777933-EF855513-BDFF-4933-8656-3758A371CE47Q26829267-42C91FA6-78CE-4103-8AD1-E9375BD8EC6BQ27008213-05BBE67D-52D5-48A5-AB29-A3F87FAE54FBQ27023047-B65E2F2E-630E-43A6-AD76-77EA0BB91EE1Q27027221-9C962343-5C3A-4F1E-BAC4-4B419F52B7D8Q27675368-533E068D-FA5B-4A27-8931-1DC027BB9AE0Q28257015-E2F97BF6-ED68-492E-90EC-60AB74D71E43Q28263028-F3DDBB70-F9BA-43B9-B587-0E48DF9CF638Q28360979-16CEA8CB-C9E3-4AD2-B6AD-DE6CF45DFC2BQ28361228-32BA520C-55E9-4F1D-B155-4D420D9DB7D3Q28587827-B10B0315-70F3-44F5-A0CA-65AFFAF1C6D3Q28829902-3789862D-74A7-4A9F-8497-D9D0FEB0EFE8Q30317236-06B114CD-A849-4379-9A67-A4C946D0C3C6Q30388923-8F48E77D-F449-462B-B5CA-0AF45AC392A2Q30396291-60ABF199-F7AC-41CC-A1ED-3DF676BC1E1EQ30462161-D0B74DA4-A764-41AF-BCC6-51C7734C723CQ30497637-CCC400B9-1CB0-4BE3-9564-6E7257D11784Q30500431-C3C7A419-DE78-4B0C-9558-EC160D992DF1Q30570526-ACC7E44F-74F6-45A9-B739-6BBC94FBF03AQ30608304-D1FA41EA-81FA-451A-AA4E-63967DD7396BQ31161261-FBB04A73-0535-4683-ACBE-4625BEB0698EQ31162477-C72BB0C6-DD9B-480C-90A0-9BE24FA0D0C1Q32162583-1F6DE889-8FFE-4AA0-8BF1-1D7B844305CAQ33423337-9BE46985-EFBC-44B6-A8F0-CB31EC2DB609Q33563579-780EFABC-0417-4403-807A-D091F8831C4DQ33575703-B403C474-955C-4397-9B68-62F7EF8FAFF2Q33575836-DF31E0F1-D3ED-4FAA-828C-F95E4C25D610Q33582060-01F82920-F746-4FC5-A070-260C52E41AB7Q33604723-2E61B276-5D58-409B-987A-944DCF99DD17Q33621904-6858A146-1E13-40F2-8B73-F52E4357F3DA
P2860
Alzheimer's disease: a disorder of cortical cholinergic innervation.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Alzheimer's disease: a disorder of cortical cholinergic innervation.
@en
type
label
Alzheimer's disease: a disorder of cortical cholinergic innervation.
@en
prefLabel
Alzheimer's disease: a disorder of cortical cholinergic innervation.
@en
P2093
P356
P1433
P1476
Alzheimer's disease: a disorder of cortical cholinergic innervation.
@en
P2093
P304
P356
10.1126/SCIENCE.6338589
P407
P577
1983-03-01T00:00:00Z